Experimental aortic aneurysm severity and growth depend on topical elastase concentration and lysyl oxidase inhibition

Sci Rep. 2022 Jan 7;12(1):99. doi: 10.1038/s41598-021-04089-8.

Abstract

Abdominal aortic aneurysm (AAA) formation and expansion is highly complex and multifactorial, and the improvement of animal models is an important step to enhance our understanding of AAA pathophysiology. In this study, we explore our ability to influence aneurysm growth in a topical elastase plus β-Aminopropionitrile (BAPN) mouse model by varying elastase concentration and by altering the cross-linking capability of the tissue. To do so, we assess both chronic and acute effects of elastase concentration using volumetric ultrasound. Our results suggest that the applied elastase concentration affects initial elastin degradation, as well as long-term vessel expansion. Additionally, we assessed the effects of BAPN by (1) removing it to restore the cross-linking capability of tissue after aneurysm formation and (2) adding it to animals with stable aneurysms to interrupt cross-linking. These results demonstrate that, even after aneurysm formation, lysyl oxidase inhibition remains necessary for continued expansion. Removing BAPN reduces the aneurysm growth rate to near zero, resulting in a stable aneurysm. In contrast, adding BAPN causes a stable aneurysm to expand. Altogether, these results demonstrate the ability of elastase concentration and BAPN to modulate aneurysm growth rate and severity. The findings open several new areas of investigation in a murine model that mimics many aspects of human AAA.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Administration, Topical
  • Aminopropionitrile*
  • Animals
  • Aorta, Abdominal / enzymology*
  • Aorta, Abdominal / pathology
  • Aortic Aneurysm, Abdominal / chemically induced*
  • Aortic Aneurysm, Abdominal / enzymology
  • Aortic Aneurysm, Abdominal / pathology
  • Dilatation, Pathologic
  • Disease Models, Animal
  • Disease Progression
  • Female
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Pancreatic Elastase*
  • Protein-Lysine 6-Oxidase / antagonists & inhibitors*
  • Protein-Lysine 6-Oxidase / metabolism
  • Severity of Illness Index

Substances

  • Aminopropionitrile
  • Protein-Lysine 6-Oxidase
  • Pancreatic Elastase